Four Points Innovation has been formed with $130m in funding to nurture Duke drug discovery research, in the latest such move by Deerfield Management.
Duke University’s Office of Licensing and Ventures yesterday joined forces with investment firm Deerfield Management to establish translational research funding and commercialisation firm Four Point Innovations.
Four Points has been equipped with $130m from Deerfield, which will be invested over 10 years. The firm will target pre-clinical research conducted by Duke in areas of high medical need and will have a licensing option on all portfolio assets.
Applications will begin in March 2020, to be assessed by joint…
